The Effects of a Customized Exercise Program on Pain, Kyphosis Angle, and Quality of Life (Exercise)

March 12, 2026 updated by: Ozden Baskan, Istanbul Rumeli University

The Effects of a Customized Exercise Program on Pain, Kyphosis Angle, and Quality of Life in Healthy Adults

The aim of this study is to evaluate the effect of a customized corrective exercise program on back pain, kyphosis degree, and quality of life in healthy adults. Our hypothesis is that healthy adults participating in a customized exercise program will show a reduction in back pain, a decrease in thoracic kyphosis angle, and an improvement in quality of life in the post-intervention period compared to the control group. The program will continue twice a week for four weeks.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • aged 18-45 years
  • diagnosed with nonspesific back pain
  • had not engaged in regular exercise for the past 6 months.
  • Volunteered to participate

Exclusion Criteria:

  • Individuals with orthopedic problems such as scoliosis or spondylolisthesis, those with acute infections or oncological, neurological, and rheumatological problems, and those already participating in a regular exercise program were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
kyphosis index
Time Frame: From enrollment to the end of treatment at 4 weeks
The terapist recorded the measurement between c7-T12 with flexiruler
From enrollment to the end of treatment at 4 weeks
Pain assessment
Time Frame: From enrollment to the end of treatment at 4 weeks
Mc Gill pain Assesment
From enrollment to the end of treatment at 4 weeks
scapular Protraction
Time Frame: from enrollment to the end of treatment at 4 weeks
The inferior angle of the scapula was identified by palpation and marked. The horizontal distance between the marked inferior angles of the scapulae was measured using a flexible measuring tape and recorded in centimeters (cm).
from enrollment to the end of treatment at 4 weeks
Cervical posture
Time Frame: 0 and 4th week
Anterior neck tilt is recorded.
0 and 4th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: from enrollmnent to the end of treatment
Sf 36 quality of life survey is recorded.
from enrollmnent to the end of treatment
Trunk flexibility measurements
Time Frame: from enrollment to the end of treatment at 4 weeks.
Trunk rotation, lateral flexion, and extension measurements are recorded.
from enrollment to the end of treatment at 4 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2026

Primary Completion (Actual)

March 5, 2026

Study Completion (Estimated)

April 5, 2026

Study Registration Dates

First Submitted

March 12, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Posture

Clinical Trials on Exercise

Subscribe